{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:24:27Z","timestamp":1786983867202,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.abb.2024.110209","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T19:20:16Z","timestamp":1730575216000},"page":"110209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["AI-assisted generation and in-depth in-silico evaluation of potential inhibitor targeting aurora kinase A (AURKA): An anticancer discovery exploiting synthetic lethality approach"],"prefix":"10.1016","volume":"762","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3256-4663","authenticated-orcid":false,"given":"Anand Kumar","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3\u20134","key":"10.1016\/j.abb.2024.110209_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1142\/S2339547818300020","article-title":"The growing role of precision and personalized medicine for cancer treatment","volume":"6","author":"Krzyszczyk","year":"2018","journal-title":"Technology"},{"issue":"1","key":"10.1016\/j.abb.2024.110209_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-019-0703-1","article-title":"Molecular profiling for precision cancer therapies","volume":"12","author":"Malone","year":"2020","journal-title":"Genome Med."},{"issue":"9","key":"10.1016\/j.abb.2024.110209_bib3","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/cncr.29140","article-title":"Therapeutic targeting of tumor suppressor genes","volume":"121","author":"Morris","year":"2015","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.abb.2024.110209_bib4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13045-020-00956-5","article-title":"Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation","volume":"13","author":"Topatana","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.abb.2024.110209_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1124147","article-title":"PARP inhibitors in the treatment of ARID1A mutant ovarian clear cell cancer: PI3K\/Akt1-dependent mechanism of synthetic lethality","volume":"13","author":"Yakovlev","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.abb.2024.110209_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13008-018-0040-6","article-title":"The functional diversity of Aurora kinases: a comprehensive review","volume":"13","author":"Willems","year":"2018","journal-title":"Cell Div."},{"issue":"5","key":"10.1016\/j.abb.2024.110209_bib7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/PPO.0000000000000614","article-title":"Aurora kinases as therapeutic targets in head and neck cancer","volume":"28","author":"Nguyen","year":"2022","journal-title":"Cancer J."},{"issue":"1","key":"10.1016\/j.abb.2024.110209_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/biom9010028","article-title":"Aurora A protein kinase: to the centrosome and beyond","volume":"9","author":"Magnaghi-Jaulin","year":"2019","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.abb.2024.110209_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/BST20160142","article-title":"Mechanisms for nonmitotic activation of Aurora-A at cilia","volume":"45","author":"Korobeynikov","year":"2017","journal-title":"Biochem. Soc. Trans."},{"issue":"5","key":"10.1016\/j.abb.2024.110209_bib10","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s12276-021-00635-6","article-title":"Aurora kinase A, a synthetic lethal target for precision cancer medicine","volume":"53","author":"Mou","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.abb.2024.110209_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12943-020-01305-3","article-title":"Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy","volume":"20","author":"Du","year":"2021","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.abb.2024.110209_bib12","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.3390\/cancers12113371","article-title":"Promising therapy in lung cancer: spotlight on aurora kinases","volume":"12","author":"Galetta","year":"2020","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.abb.2024.110209_bib13","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1016\/j.apsb.2023.03.013","article-title":"Emerging roles of Aurora-A kinase in cancer therapy resistance","volume":"13","author":"Zheng","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.abb.2024.110209_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-017-0483-2","article-title":"SIX3, a tumor suppressor, inhibits astrocytoma tumorigenesis by transcriptional repression of AURKA\/B","volume":"10","author":"Yu","year":"2017","journal-title":"J. Hematol. Oncol."},{"issue":"14","key":"10.1016\/j.abb.2024.110209_bib15","doi-asserted-by":"crossref","first-page":"23937","DOI":"10.18632\/oncotarget.14893","article-title":"Aurora kinases: novel therapy targets in cancers","volume":"8","author":"Tang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.abb.2024.110209_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13641","article-title":"The role of Aurora kinase A in hepatocellular carcinoma: unveiling the intriguing functions of a key but still underexplored factor in liver cancer","author":"Grisetti","year":"2024","journal-title":"Cell Prolif."},{"issue":"11","key":"10.1016\/j.abb.2024.110209_bib17","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.3390\/cancers12113371","article-title":"Promising therapy in lung cancer: spotlight on aurora kinases","volume":"12","author":"Galetta","year":"2020","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.abb.2024.110209_bib18","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jamaoncol.2022.7949","article-title":"Evaluation of Alisertib alone or combined with fulvestrant in patients with Endocrine-Resistant advanced breast Cancer","volume":"9","author":"Haddad","year":"2023","journal-title":"JAMA Oncol."},{"issue":"6","key":"10.1016\/j.abb.2024.110209_bib19","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1021\/ml500409n","article-title":"MLN8054 and Alisertib (MLN8237): discovery of selective oral aurora A inhibitors","volume":"6","author":"Sells","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.abb.2024.110209_bib20","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1158\/1078-0432.CCR-18-2675","article-title":"A phase II study of Alisertib in children with recurrent\/refractory solid tumors or leukemia: children's oncology group phase I and pilot consortium (ADVL0921)","volume":"25","author":"Moss\u00e9","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.abb.2024.110209_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drudis.2020.10.010","article-title":"Artificial intelligence in drug discovery and development","volume":"26","author":"Paul","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.abb.2024.110209_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-58122-7","article-title":"Machine learning accelerates pharmacophore-based virtual screening of MAO inhibitors","volume":"14","author":"Cie\u015blak","year":"2024","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.abb.2024.110209_bib23","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/s41591-023-02361-0","article-title":"Inside the nascent industry of AI-designed drugs","volume":"29","author":"Arnold","year":"2023","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.abb.2024.110209_bib24","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1021\/acs.jcim.3c01979","article-title":"MolProphet: a one-stop, general purpose, and AI-based platform for the early stages of drug discovery","volume":"64","author":"Yang","year":"2024","journal-title":"J. Chem. Inf. Model."},{"issue":"4","key":"10.1016\/j.abb.2024.110209_bib25","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1021\/cb200508b","article-title":"A novel mechanism by which small molecule inhibitors induce the DFG flip in aurora A","volume":"7","author":"Martin","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.abb.2024.110209_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"W1","key":"10.1016\/j.abb.2024.110209_bib27","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.abb.2024.110209_bib28","unstructured":"Online SMILES Translator and Structure File Generator, NCI\/CADD Group, National Cancer Institute, U.S.A."},{"issue":"16","key":"10.1016\/j.abb.2024.110209_bib29","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.abb.2024.110209_bib30","unstructured":"PyMOL, The PyMOL Molecular Graphics System, Version 3.0 Schr\u00f6dinger, LLC."},{"key":"10.1016\/j.abb.2024.110209_bib31","series-title":"Discovery Studio","year":"2020"},{"issue":"D1","key":"10.1016\/j.abb.2024.110209_bib32","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.abb.2024.110209_bib33","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/bioinformatics\/btt055","article-title":"Gromacs 4.5: a high-throughput and highly parallel open source molecular simulation toolkit","volume":"29","author":"Pronk","year":"2013","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.abb.2024.110209_bib34","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.abb.2024.110209_bib35","series-title":"Origin (Pro)","year":"2024"},{"issue":"6","key":"10.1016\/j.abb.2024.110209_bib36","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","article-title":"Molecular dynamics simulation for all","volume":"99","author":"Hollingsworth","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.abb.2024.110209_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/bs.mie.2020.04.020","article-title":"A beginner's guide to molecular dynamics simulations and the identification of cross-correlation networks for enzyme engineering","volume":"643","author":"Yu","year":"2020","journal-title":"Methods Enzymol."},{"issue":"5","key":"10.1016\/j.abb.2024.110209_bib38","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expet Opin. Drug Discov."},{"issue":"10","key":"10.1016\/j.abb.2024.110209_bib39","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"issue":"11","key":"10.1016\/j.abb.2024.110209_bib40","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/jcc.10244","article-title":"Parameterization of charge model 3 for AM1, PM3, BLYP, and B3LYP","volume":"24","author":"Thompson","year":"2003","journal-title":"J. Comput. Chem."},{"issue":"5","key":"10.1016\/j.abb.2024.110209_bib41","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrg.2016.13","article-title":"Epigenetic modulators, modifiers and mediators in cancer aetiology and progression","volume":"17","author":"Feinberg","year":"2016","journal-title":"Nat. Rev. Genet."},{"issue":"6","key":"10.1016\/j.abb.2024.110209_bib42","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1159\/000495956","article-title":"Loss of tumor suppressor gene Function in human Cancer: an Overview","volume":"51","author":"Wang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"3","key":"10.1016\/j.abb.2024.110209_bib43","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ccr.2014.07.015","article-title":"Drugging MYCN through an allosteric transition in aurora kinase A","volume":"26","author":"Gustafson","year":"2014","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.abb.2024.110209_bib44","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nchem.1243","article-title":"Quantifying the chemical beauty of drugs","volume":"4","author":"Bickerton","year":"2012","journal-title":"Nat. Chem."},{"issue":"3","key":"10.1016\/j.abb.2024.110209_bib45","first-page":"845","article-title":"Alisertib induces G2\/M arrest, apoptosis, and autophagy via PI3K\/Akt\/mTOR- and p38 MAPK-mediated pathways in human glioblastoma cells","volume":"9","author":"Liu","year":"2017","journal-title":"Am. J. Tourism Res."},{"issue":"1","key":"10.1016\/j.abb.2024.110209_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/srep34984","article-title":"Structural insights into conformational stability of both wild-type and mutant EZH2 receptor","volume":"6","author":"Aier","year":"2016","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.abb.2024.110209_bib47","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1089\/cmb.2013.0071","article-title":"Protein depth calculation and the use for improving accuracy of protein fold recognition","volume":"20","author":"Xu","year":"2013","journal-title":"J. Comput. Biol."},{"issue":"8","key":"10.1016\/j.abb.2024.110209_bib48","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1021\/acscentsci.9b00200","article-title":"Explicit characterization of the free energy landscape of pKID-KIX coupled folding and binding","volume":"5","author":"Chong","year":"2019","journal-title":"ACS Cent. Sci."},{"issue":"8","key":"10.1016\/j.abb.2024.110209_bib49","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jmgm.2009.01.006","article-title":"Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case","volume":"27","author":"Papaleo","year":"2009","journal-title":"J. Mol. Graph. Model."},{"issue":"11","key":"10.1016\/j.abb.2024.110209_bib50","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1039\/D1ME00053E","article-title":"On the estimation of the molecular inaccessible volume and the molecular accessible surface of a ligand in protein\u2013ligand systems","volume":"6","author":"Konstantinidis","year":"2021","journal-title":"Molecular Systems Design & Engineering"},{"issue":"2","key":"10.1016\/j.abb.2024.110209_bib51","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/ijms17020144","article-title":"Insights into protein-ligand interactions: mechanisms, models, and methods","volume":"17","author":"Du","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.abb.2024.110209_bib52","article-title":"Probing Origin of binding difference of inhibitors to MDM2 and MDMX by polarizable molecular dynamics simulation and QM\/MM-GBSA calculation","volume":"5","author":"Chen","year":"2015","journal-title":"Sci. Rep."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000398612400331X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000398612400331X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T09:03:39Z","timestamp":1733389419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000398612400331X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":52,"alternative-id":["S000398612400331X"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2024.110209","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AI-assisted generation and in-depth in-silico evaluation of potential inhibitor targeting aurora kinase A (AURKA): An anticancer discovery exploiting synthetic lethality approach","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2024.110209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110209"}}